CompletedPhase 3Phase 4ACTRN12607000367448

The long term effect of inhaled hypertonic saline (6%) in non-cystic fibrosis bronchiectasis.

The long term effect of inhaled hypertonic saline (6%) on pulmonary exacerbations, quality of life and lung function in patients with non-cystic fibrosis bronchiectasis.

Sponsor

Alfred Hospital, Physiotherapy Department

Enrollment

40 participants

Start Date

Dec 20, 2007

Study Type

Interventional

Conditions

Non-cystic fibrosis bronchiechtasis

Summary

The main purpose of this study is to determine whether the long term inhalation of a salt solution will decrease the number of lung infections and improve the quality of life of people with bronchiectasis.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study investigates the long term effect of inhaled hypertonic saline (6%) in non-cystic fibrosis bronchiectasis. It is looking for both men and women, aged 18 and older who have diagnosis of bronchiectasis using high resolution computer tomography (HRCT), at least two pulmonary exacerbations over past year, producing sputum.... If you are interested, you may need to attend study visits and follow the research team's instructions.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Hypertonic saline (6%) - 5mls nebulsied twice a day for 12 months

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000367448